SCHEMBL8347189

SCHEMBL8347189

CC12NS(=O)(=O)c3cccc(c31)C(=O)c1ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
CA4 P22748 2/20 0.39
CA7 P43166 2/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
BCHE P06276 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
KMT2A Q03164 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
KCNQ2 O43526 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29836249 0.69 KDM4E (0.44) CA12CA1CA2CA9CA4
SCHEMBL448460 0.69 KMT2A (0.39) CA12CA1CA2CA9CA4
SCHEMBL21910775 0.68 CA9 (0.48) CA12CA1CA2CA9CA4
SCHEMBL29522682 0.67 MEN1 (0.52) KDM4ELMNABCHEKMT2AKCNQ2
SCHEMBL12997894 0.67 MEN1 (0.52) KDM4ELMNABCHEKMT2AKCNQ2
SCHEMBL12997896 0.67 MEN1 (0.52) KDM4ELMNABCHEKMT2AKCNQ2
SCHEMBL1855552 0.67 MEN1 (0.52) KDM4ELMNABCHEKMT2AKCNQ2
Ammonia Solution, Strong SCHEMBL446104 0.67 KMT2A (0.38) CA12CA1CA2CA9CA4
SCHEMBL11482321 0.64 MEN1 (0.48) CA1CA2CA9CA7KDM4E
SCHEMBL883417 0.62 DAO (0.43) CA1CA2CA9CA7KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003102151-A2 MODULATING CELL DIFFERENTIATION AND TREATING MYELOPROLIFERTIVE DISORDERS WITH JNK/MKK INHIBITORS CELGENE CORPORATION (US) 2003-12-11 WO disclosed